Loading...
XJPX
4368
Market cap2.60bUSD
Jul 10, Last price  
4,040.00JPY
1D
1.13%
1Q
32.46%
Jan 2017
60.89%
IPO
1,246.67%
Name

Fuso Chemical Co Ltd

Chart & Performance

D1W1MN
XJPX:4368 chart
P/E
29.87
P/S
5.56
EPS
135.27
Div Yield, %
1.98%
Shrs. gr., 5y
-0.14%
Rev. gr., 5y
12.75%
Revenues
76.93b
+10.68%
27,059,879,00030,833,544,00030,077,903,00029,798,417,00030,251,938,00028,247,878,00027,355,000,00029,327,000,00032,223,000,00035,298,000,00036,224,000,00040,221,000,00042,074,000,00041,310,000,00042,209,000,00055,760,000,00068,459,000,00058,970,000,00069,501,000,00076,926,023,000
Net income
14.31b
+23.14%
1,409,907,0001,760,763,000209,636,0001,435,086,0002,331,386,0002,508,189,0001,903,000,0002,258,000,0003,452,000,0004,716,000,0006,895,000,0006,592,000,0006,881,000,0007,014,000,0006,808,000,00010,890,000,00014,129,000,0008,343,000,00011,622,000,00014,311,582,000
CFO
24.79b
+9.08%
2,859,380,0003,878,081,0001,748,283,0007,007,945,0005,321,184,0001,838,731,0004,266,589,0003,573,386,0006,369,454,0008,086,532,0009,413,515,0004,845,599,0008,148,493,00011,936,908,00012,820,551,00010,199,062,00013,931,146,0007,081,634,00022,729,527,00024,793,525,000
Dividend
Sep 29, 202614 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1952 and headquartered in Osaka, Japan, Fuso Chemical Co.,Ltd. operates globally, specializing in the manufacturing and distribution of a diverse portfolio spanning life science, electronic material, and functional chemical products. The company's life science division offers a comprehensive array of organic acids and their derivatives, including malic, citric, L-tartaric, lactic, and gluconic acids, as well as ascorbic, isoascorbic acids, and amino acid compounds. This segment also provides industrial solutions such as water-soluble rust-preventive agents and grinding/cutting fluids. For the electronics industry, Fuso Chemical produces ultra-high purity colloidal silica and high-purity organosilica sol. Additionally, its functional chemical offerings encompass various oxidation-reduction agents and benzoic acid derivatives.
IPO date
May 30, 2001
Employees
859
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT